Gemfibrozil and muscular weakness Patient Reports February 10, 2012

Gemfibrozil Side Effects Report #5737943-2
Gemfibrozil side effect was reported by a Pharmacist from UNITED STATES on May 12, 2008. Male patient, 67 years of age, weighting 218.3 lb, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: arthralgia, blood creatine phosphokinase increased, blood triglycerides increased, hepatic enzyme increased, muscular weakness, myalgia, renal failure acute. Gemfibrozil dosage: 600 MG BID PO. During the same period patient was treated with SIMVASTATIN. Patient was hospitalized and became disabled. Patient recovered.

Gemfibrozil Side Effects Report #5456736-7
Gemfibrozil side effect was reported by a Pharmacist from UNITED STATES on Sept 17, 2007. Male patient, 62 years of age, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, chromaturia, muscular weakness. Gemfibrozil dosage: 600MG BID PO. During the same period patient was treated with SIMVASTATIN. Patient recovered.

Gemfibrozil Side Effects Report #5215462-X
Gemfibrozil side effect was reported by a Pharmacist from UNITED STATES on Jan 19, 2007. Male patient, 60 years of age, weighting 181.0 lb, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: hepatotoxicity, muscular weakness, renal failure. Gemfibrozil dosage: 600MG BID PO. During the same period patient was treated with FLUVASTATIN, LISINOPRIL, METOPROLOL TARTRATE, FELODIPINE. Patient was hospitalized. Patient recovered.

Gemfibrozil Side Effects Report #4948669-7
Gemfibrozil side effect was reported by a Physician from SWITZERLAND on Feb 27, 2006. Male patient, 60 years of age, was diagnosed with hypercholesterolaemia and was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, intervertebral disc displacement, liver disorder, muscular weakness, myalgia, myopathy, spinal column stenosis. Gemfibrozil dosage: 450 MG (450 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SELIPRAN, ASPIRIN, CITALOPRAM, DIOVAN HCT, ATENOLOL, NEXIUM. Patient recovered.


Gemfibrozil Side Effects Report #5688350-2
Gemfibrozil side effect was reported by a Pharmacist from UNITED STATES on Mar 28, 2008. Male patient, 59 years of age, was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, dysstasia, hepatic enzyme increased, muscular weakness, myalgia. Gemfibrozil dosage: unknown. During the same period patient was treated with SIMVASTATIN. Patient was hospitalized. Patient recovered.

Gemfibrozil Side Effects Report #5148327-2
Gemfibrozil side effect was reported by a Consumer or non-health professional from FRANCE on Oct 26, 2006. Male patient, 51 years of age, was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: abdominal pain upper, arthropathy, asthenia, dysphagia, muscular weakness, myalgia, skin reaction, urticaria. Gemfibrozil dosage: unknown. During the same period patient was treated with METRONIDAZOLE. Patient recovered.